Finland· FI-REL-REL61344
Bcg-Medac
A bcg-impfstoff product containing bacillus calmette guerin bacteria, live, attenuated, registered in Finland by Orifarm Oy. The same ATC class is registered in 11 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Bcg-impfstoff is registered in 11 of 19 countries.
Countries holding a registration under ATC L03AX03 (bcg-impfstoff), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Bcg-impfstoff · ATC L03AX03
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Bacillus Calmette Guerin bacteria, live, attenuated
- Manufacturer
- Orifarm Oy
- Country
- Finland (FI)
- ATC code
- L03AX03
- ATC class
- BCG-Impfstoff
- Defined daily dose
- 0.033 Darreichungsform, intravesikal
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 4
4 priced- fi_myyntilupa4261193 + 3 x 50 mlEUR 681.82
- fi_myyntilupa4996773 + 3 x 50 mlEUR 681.82
- fi_myyntilupa3994113 + 3 x 50 mlEUR 681.82
- fi_myyntilupa3762963 + 3 x 50 mlEUR 668.33
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under L03AX03
Bcg-impfstoff, as other registers publish it.
- PolandBCG - medacmedac Gesellschaft fuer klinische Spezialpraeparate mbH
- DenmarkBCG "medac"Medac, Gesellschaft für klinische Spezialpräparate mbH
- SwitzerlandBCG Apogepha 100 mg, Pulver und Lösungsmittel zur Herstellung einer Suspension zur intravesikalen AnwendungRegulix GmbH
- SwitzerlandBCG Apogepha 50 mg, Pulver und Lösungsmittel zur Herstellung einer Suspension zur intravesikalen AnwendungRegulix GmbH
- DenmarkBCG medac2care4 ApS
- CzechiaBCG MEDACMedac Gesellschaft für klinische Spezialpräparate m.b.H., Wedel
- CzechiaBCG MEDACMedac Gesellschaft für klinische Spezialpräparate m.b.H., Wedel
- CzechiaBCG MEDACMedac Gesellschaft für klinische Spezialpräparate m.b.H., Wedel
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f05ec95a-687c-46f5-a753-8d159f3cb2cc GET /v1/drugs/f05ec95a-687c-46f5-a753-8d159f3cb2cc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "1.8",
"form": "jauhe ja liuotin suspensiota varten, virtsarakkoon",
"route": "Virtsarakkoon",
"ddd_unit": "mg",
"strength": null,
"atc_label": "BCG-rokote",
"ma_number": "42283",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL61344",
"authorised_at": "2023-09-13"
}See everything about bcg-impfstoff.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.